Top compounds associated with response to EFCAB13


Feature Type Standardized
Nominal ANOVA
mRNA SGC0946 GDSC1000 pan-cancer AAC 0.069 0.05
mRNA thapsigargin gCSI pan-cancer AAC -0.11 0.05
mRNA BRD-K90370028 CTRPv2 pan-cancer AAC 0.11 0.05
mRNA Vandetanib CCLE pan-cancer AAC -0.092 0.05
mRNA Erlotinib GDSC1000 pan-cancer AAC -0.092 0.06
mRNA paclitaxel CCLE pan-cancer AAC -0.088 0.06
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.06
mRNA Merck60 CTRPv2 pan-cancer AAC -0.057 0.06
mRNA AS605240 GDSC1000 pan-cancer AAC 0.061 0.06
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.06
Download CSV